MORRISVILLE, North Carolina, May 16, 2016 /PRNewswire/ --
"The relationship between a sponsor and CRO is critical to the successful execution of a clinical trial," explains Ronniger. "Effective planning and risk sharing, unique governance models, open and ongoing communication, and frequent measurement and reporting - these things are all key to achieving positive study outcomes. I will explore how to put these strategies into practice to ensure their study programs are delivered to the highest quality, within budget and to timescales."
In addition to Ronniger's presentation, experts from the Worldwide Clinical Trials team will be available at booth #9 throughout OCT-EU to discuss attendees' individual drug development challenges as well as their concerns and needs across a range of therapeutic areas, including neuroscience, cardiovascular disease, inflammatory disorders, and rare disease.
OCT-EU offers two days of interactive sessions focused on building partnerships and optimizing operational strategies within clinical trials. For further information about OCT-EU, visit http://www.arena-international.com/octeurope/
Connect with Worldwide Clinical Trials:
About Worldwide Clinical Trials Worldwide Clinical Trials employs more than 1,400 professionals around the world, with offices in North and South America, Eastern and Western Europe, Russia and Asia. One of the world's leading, full-service contract research organizations (CROs), we partner with sponsors in the pharmaceutical and biotechnology industries to deliver fully integrated clinical development and bioanalytical services, extending from first-in-human through phase IV studies. Grounded in medicine and science, we help sponsors move from medical discovery into clinical development and commercialization across a range of therapeutic areas, including neuroscience, cardiovascular diseases, immune-mediated inflammatory disorders (IMID), and rare diseases. For more information, visit http://www.Worldwide.com .
SOURCE Worldwide Clinical Trials
Subscribe to our Free Newsletters!
Angiogenesis is the process of formation of new blood vessels from pre-existing blood vessels. It ...
Aniridia is a genetic eye disorder in which the iris is partially or entirely absent. It is ...
Cachexia refers to severe muscle and fat loss, anorexia and marked weight loss due to an underlying ...View All